Ventas (NYSE:VTR) Updates FY 2026 Earnings Guidance

Ventas (NYSE:VTR) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 3.820-3.890 for the period, compared to the consensus earnings per share estimate of 3.880. The company issued revenue guidance of -.

Ventas Price Performance

VTR opened at $83.85 on Wednesday. The stock has a market cap of $40.76 billion, a price-to-earnings ratio of 152.46, a PEG ratio of 1.80 and a beta of 0.71. Ventas has a 1 year low of $61.76 and a 1 year high of $91.06. The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 0.95. The stock has a fifty day moving average price of $85.16 and a 200 day moving average price of $82.56.

Ventas (NYSE:VTR) last released its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). The firm had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. Ventas’s revenue for the quarter was up 22.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.84 EPS. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Analysts forecast that Ventas will post 3.88 EPS for the current fiscal year.

Ventas Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, July 16th. Investors of record on Tuesday, June 30th will be given a dividend of $0.52 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. Ventas’s dividend payout ratio (DPR) is presently 378.18%.

Wall Street Analysts Forecast Growth

VTR has been the subject of a number of research reports. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $100.00 price objective on shares of Ventas in a research report on Tuesday. Royal Bank Of Canada lifted their price objective on Ventas from $91.00 to $98.00 and gave the company an “outperform” rating in a research report on Monday, May 4th. BMO Capital Markets reissued an “outperform” rating and set a $100.00 price objective on shares of Ventas in a research report on Monday, May 4th. JPMorgan Chase & Co. boosted their price target on Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a research report on Monday, May 11th. Finally, Evercore reaffirmed an “outperform” rating and issued a $95.00 price target on shares of Ventas in a research report on Wednesday, April 29th. Fifteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $96.41.

Insider Transactions at Ventas

In related news, Director Walter C. Rakowich sold 1,152 shares of the business’s stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $90.20, for a total transaction of $103,910.40. Following the completion of the transaction, the director owned 28,349 shares of the company’s stock, valued at approximately $2,557,079.80. The trade was a 3.90% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler acquired 2,500 shares of the business’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were acquired at an average cost of $78.81 per share, with a total value of $197,025.00. Following the transaction, the director directly owned 19,202 shares in the company, valued at $1,513,309.62. The trade was a 14.97% increase in their position. The SEC filing for this purchase provides additional information. 0.53% of the stock is owned by insiders.

Hedge Funds Weigh In On Ventas

Several large investors have recently made changes to their positions in the business. IHT Wealth Management LLC lifted its position in shares of Ventas by 3.2% during the 4th quarter. IHT Wealth Management LLC now owns 4,415 shares of the real estate investment trust’s stock worth $343,000 after purchasing an additional 137 shares during the last quarter. Parallel Advisors LLC lifted its position in shares of Ventas by 4.6% during the 3rd quarter. Parallel Advisors LLC now owns 3,970 shares of the real estate investment trust’s stock worth $278,000 after purchasing an additional 175 shares during the last quarter. Advisory Services Network LLC lifted its position in shares of Ventas by 5.3% during the 4th quarter. Advisory Services Network LLC now owns 3,805 shares of the real estate investment trust’s stock worth $294,000 after purchasing an additional 190 shares during the last quarter. Lido Advisors LLC lifted its position in shares of Ventas by 3.2% during the 4th quarter. Lido Advisors LLC now owns 6,239 shares of the real estate investment trust’s stock worth $451,000 after purchasing an additional 192 shares during the last quarter. Finally, Rossby Financial LCC lifted its position in shares of Ventas by 45.8% during the 4th quarter. Rossby Financial LCC now owns 729 shares of the real estate investment trust’s stock worth $56,000 after purchasing an additional 229 shares during the last quarter. Institutional investors and hedge funds own 94.18% of the company’s stock.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.